Home Value Investing Aswath Damodaran – Checkmate or Stalemate: Valeant’s fall from investing grace

Aswath Damodaran – Checkmate or Stalemate: Valeant’s fall from investing grace

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.


Checkmate or Stalemate: Valeant’s fall from investing grace

Published on Nov 13, 2015

In this session, I look at Valeant’s rise from obscure Canadian drug company to a value investing darling, and its precipitous fall in the last three weeks.
Slides: http://www.stern.nyu.edu/~adamodar/pd…
Valuation: http://www.stern.nyu.edu/~adamodar/pc…
Blog Post: http://aswathdamodaran.blogspot.com/2…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...